Takai N - Search Results

1

Array-based approaches for the identification of epigenetic silenced tumor suppressor genes.

Takai N, Narahara H. Takai N, et al. Curr Genomics. 2008 Mar;9(1):22-4. doi: 10.2174/138920208783884892. Curr Genomics. 2008. PMID: 19424480 Free PMC article.

2

Human endometrial and ovarian cancer cells: histone deacetylase inhibitors exhibit antiproliferative activity, potently induce cell cycle arrest, and stimulate apoptosis.

Takai N, Narahara H. Takai N, et al. Curr Med Chem. 2007;14(24):2548-53. doi: 10.2174/092986707782023299. Curr Med Chem. 2007. PMID: 17979707 Review.

3

Epigenetic therapy in human choriocarcinoma.

Takai N, Narahara H. Takai N, et al. Cancers (Basel). 2010 Sep 10;2(3):1683-8. doi: 10.3390/cancers2031683. Cancers (Basel). 2010. PMID: 24281181 Free PMC article.

4

C2-ceramide exhibits antiproliferative activity and potently induces apoptosis in endometrial carcinoma.

Takai N, Ueda T, Kawano Y, Nishida M, Nasu K, Narahara H. Takai N, et al. Oncol Rep. 2005 Nov;14(5):1287-91. Oncol Rep. 2005. PMID: 16211298

5

M344 is a novel synthesized histone deacetylase inhibitor that induces growth inhibition, cell cycle arrest, and apoptosis in human endometrial cancer and ovarian cancer cells.

Takai N, Ueda T, Nishida M, Nasu K, Narahara H. Takai N, et al. Gynecol Oncol. 2006 Apr;101(1):108-13. doi: 10.1016/j.ygyno.2005.09.044. Epub 2005 Nov 2. Gynecol Oncol. 2006. Retraction in: Gynecol Oncol. 2013 Apr;129(1):270. doi: 10.1016/j.ygyno.2012.09.022. PMID: 16263156 Retracted.

6

A novel histone deacetylase inhibitor, Scriptaid, induces growth inhibition, cell cycle arrest and apoptosis in human endometrial cancer and ovarian cancer cells.

Takai N, Ueda T, Nishida M, Nasu K, Narahara H. Takai N, et al. Int J Mol Med. 2006 Feb;17(2):323-9. Int J Mol Med. 2006. PMID: 16391833

7

CBHA is a family of hybrid polar compounds that inhibit histone deacetylase, and induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells.

Takai N, Ueda T, Nishida M, Nasu K, Matsuda K, Kusumoto M, Narahara H. Takai N, et al. Oncology. 2006;70(2):97-105. doi: 10.1159/000092585. Epub 2006 Apr 4. Oncology. 2006. Retraction in: Oncology. 2015;88(5):320. doi: 10.1159/000375387. PMID: 16601366 Retracted.

8

Anticancer activity of MS-275, a novel histone deacetylase inhibitor, against human endometrial cancer cells.

Takai N, Ueda T, Nishida M, Nasu K, Narahara H. Takai N, et al. Anticancer Res. 2006 Mar-Apr;26(2A):939-45. Anticancer Res. 2006. Retraction in: Anticancer Res. 2015 Apr;35(4):2478.. PMID: 16619490 Free article. Retracted.

9

Apicidin, a novel histone deacetylase inhibitor, has profound anti-growth activity in human endometrial and ovarian cancer cells.

Ueda T, Takai N, Nishida M, Nasu K, Narahara H. Ueda T, et al. Among authors: takai n. Int J Mol Med. 2007 Feb;19(2):301-8. Int J Mol Med. 2007. PMID: 17203205

10

Histone deacetylase inhibitors induce growth inhibition, cell cycle arrest and apoptosis in human choriocarcinoma cells.

Takai N, Ueda T, Nishida M, Nasu K, Narahara H. Takai N, et al. Int J Mol Med. 2008 Jan;21(1):109-15. Int J Mol Med. 2008. PMID: 18097623

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

310 results

Search Page